BOROSIL SCIENTIFIC LTD is a Industrial Products company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 395 | 438 | 467 |
| EBITDA (ex other income) | 45 | 53 | 54 |
| margin % | 11.5 | 12.0 | 11.5 |
| Owners' profit | 24 | 27 | 35 |
| EPS, as reported (₹) | 2.65 | 3.02 | 3.89 |
| ROE % · ROCE % | 6.2 · 8.7 | 6.6 · 9.9 | 7.8 · 9.6 |
| Debt / equity (x) | 0.04 | 0.03 | 0.02 |
| Cash from operations | 30 | 120 | 43 |
| Capex | (13) | (14) | (28) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 103 | 101 | 129 | 96 | 107 | 121 | 143 | 107 |
| Profit before tax | 12 | 7 | 14 | (4) | 5 | 13 | 29 | 6 |
| Net profit | 9 | 4 | 9 | (4) | 3 | 9 | 27 | 4 |
| EPS (₹) | 0.99 | 0.48 | 0.98 | (0.47) | 0.32 | 0.98 | 3.06 | 0.49 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Scientific-Laboratory Glass and Equipment and process system | 110 | 23.5 |
| Glassware | 131 | 28.0 |
| Others | 6 | 1.2 |
| Scientific – Laboratory Glass & equipment and Process System | 221 | 47.4 |
| Total, before eliminations | 467 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 2 Sept 2026 · Borosil Scientific publishes newspaper ad for FY26 annual report and 35th AGM notice | compliance | minimal | — | — |
| 1 Sept 2026 · Borosil Scientific sends FY26 Annual Report web link, 35th AGM on Sept 25 | compliance | minimal | — | — |
| 1 Sept 2026 · Borosil Scientific 35th AGM notice and FY26 Annual Report filed | board shareholder meetings | low | — | — |
| 28 Aug 2026 · Borosil Scientific notifies 35th AGM through newspaper advertisements | compliance | minimal | — | — |
| 28 Aug 2026 · Borosil Scientific 35th AGM set for September 25, 2026 via video call | board shareholder meetings | low | — | — |
| 13 Aug 2026 · Borosil Scientific allots 4,475 shares under ESOP scheme | capital market events | low | — | — |
| 5 Aug 2026 · Borosil Scientific Q1FY27 results: Revenue up 11%, PAT turns positive | investor communications | medium | — | — |
| 3 Aug 2026 · Q1 FY27: Revenue up 12%, PAT at Rs 6.84 cr vs Rs 0.46 cr YoY | results | high | — | — |
| 3 Aug 2026 · Borosil Scientific Q1 FY27 results: PAT jumps to Rs 6.84 cr, ESOP amendments cleared | results | high | — | — |
| 27 Jul 2026 · Borosil Scientific board to consider Q1FY27 results on Aug 3 | results | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| BOROSIL RENEWABLES LTD |
| 6,944 |
| 18.0 |
| 4.60 |
| 27.9 |
| 8.4 |
| 8.8 |
| — |
| 34.8 |
| BOROSIL SCIENTIFIC LTD ◆ | 1,116 | 25.9 | 2.53 | 17.6 | 7.8 | 9.4 | — | 10.4 |
| AGARWAL FORTUNE INDIA LIMITED | 6 | 100.1 | 8.58 | — | 8.6 | 2.5 | — | 20.8 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 25.9 | 18.8 | 228 of 366 | 38% |
| P/B | 2.5 | 2.1 | 183 of 315 | 42% |
| ROCE | 9.4 | 9.6 | 194 of 382 | 49% |
| ROE | 7.8 | 8.7 | 187 of 343 | 46% |
| Debt / Equity | 0.0 | 0.2 | 93 of 343 | 73% |
| EBITDA margin | 10.4 | 11.9 | 182 of 317 | 43% |
| Revenue growth | 11.2 | 13.7 | 172 of 311 | 45% |
| Profit growth | 203.5 | 25.5 | 50 of 314 | 84% |
| Market cap | 1116 | 226 | 118 of 382 | 69% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
